Device type · JXI
Cuff, Nerve
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JXI
Neurology
Device class
Class II
FDA decisions since 2015
24
510(k), De Novo and PMA
Adverse event reports
26
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Cuff, Nerve
- Product code
- JXI
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5275
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for JXI
Latest FDA decisions
The 8 newest of 24 since 2015.
- SILKBridge510(k)
K260245 · Decided Apr 9, 2026 · 72 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
- NeuroSpan Bridge510(k)
Auxilium Biotechnologies, Inc.
K253363 · Decided Jan 17, 2026 · 109 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
K251505 · Decided Jul 22, 2025 · 67 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
21 more FDA decisions with a free account
Reports received
26
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1
3.8% of reports
Injury reports
25
96% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 5 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 1 | 1 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 1 | 2 | 0 | 0 |
| Jun 24 | 0 | 1 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 1 | 0 | 0 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 0 | 5 | 0 | 0 |
| Nov 24 | 0 | 3 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 1 | 0 | 0 |
| Apr 25 | 0 | 1 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 0 | 1 | 0 | 0 |
| Jul 25 | 0 | 1 | 0 | 0 |
| Aug 25 | 0 | 1 | 0 | 0 |
| Sep 25 | 0 | 3 | 0 | 0 |
| Oct 25 | 0 | 3 | 0 | 0 |
| Nov 25 | 0 | 2 | 0 | 0 |
| Dec 25 | 0 | 2 | 0 | 0 |
| Jan 26 | 0 | 1 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 1 | 0 | 0 |
| Apr 26 | 0 | 3 | 0 | 0 |
| May 26 | 0 | 2 | 0 | 0 |
| Jun 26 | 0 | 3 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 1 | 1 | 0 | 0 |
| Sep 26 | 0 | 7 | 0 | 0 |
| Oct 26 | 0 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Axogen23
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem22
- Device Appears to Trigger Rejection2
- Migration2
5 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Medical device site infection6
- Pain5
- Inflammation4
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- GEM NEUROTUBE, Absorbable Woven Polyglycolic Acid Mesh Tube, Product Codes: a) 5311-01240-010, b) 5311-01240-012; for peripheral nerve repairOpen, Classified
Z-1461-2023 · Started Mar 27, 2023 · Posted by FDA Apr 25, 2023
Reason given: The product is brittle and potentially crumbling upon handling or when being removed from its package.
Cause as FDA categorized it: Under Investigation by firm
Z-1470-2020 · Started Feb 7, 2020
Reason given: Nonconforming product which was dispositioned for rejection was mistakenly released for commercial use.
Cause as FDA categorized it: Labeling mix-ups
Integra LifeSciences Corporation
Z-1286-2013 · Started Mar 28, 2013 · Posted by FDA May 10, 2013
Reason given: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
Cause as FDA categorized it: Process control
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.